Cargando…
Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity
BACKGROUND: Breast cancer cells frequently metastasize to the skeleton and induce extensive bone destruction. Cancer cells produce proteinases, including matrix metalloproteinases (MMPs) and the plasminogen activator system (PAS) which promote invasion of extracellular matrices, but whether these pr...
Autores principales: | Morgan, Hayley, Hill, Peter A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548674/ https://www.ncbi.nlm.nih.gov/pubmed/15701164 http://dx.doi.org/10.1186/1475-2867-5-1 |
Ejemplares similares
-
High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2)
por: Borrirukwanit, Kulrut, et al.
Publicado: (2014) -
Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells
por: Vial, Daniel, et al.
Publicado: (2006) -
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2000) -
Close relationship of tissue plasminogen activator-plasminogen
activator inhibitor-1 complex with multiple organ dysfunction syndrome
investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001) -
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
por: Kim, Tae-Dong, et al.
Publicado: (2006)